
CAS 1432500-66-7
:Formula:C26H26N2O5
InChI:InChI=1S/C26H26N2O5/c29-23(20-11-5-6-12-21(20)26(32)33)27-14-13-16-7-1-2-8-17(16)22(27)15-28-24(30)18-9-3-4-10-19(18)25(28)31/h1-4,7-10,20-22H,5-6,11-15H2,(H,32,33)/t20-,21+,22-/m1/s1
InChI key:LNENLABLFGGAFF-BHIFYINESA-N
SMILES:C1CC[C@@H]([C@@H](C1)C(=O)N2CCC3=CC=CC=C3[C@H]2CN4C(=O)C5=CC=CC=C5C4=O)C(=O)O
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
ML334
CAS:ML334 (LH601A) is an NRF2 activator that inhibits cardiac fibroblast activation and proliferation ameliorating myocardial infarction-induced cardiac fibrosis.Formula:C26H26N2O5Purity:98.06% - 98.06%Color and Shape:SolidMolecular weight:446.495ML334
CAS:(1S,2R)-2-((S)-1-((1,3-Dioxoisoindolin-2-yl)methyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)cyclohexane-1-carboxylic acidFormula:C26H26N2O5Purity:98%Molecular weight:446.5ML 334
CAS:ML 334 is a drug that has been developed to treat cancer. It is an inhibitor of the enzyme 18-alpha-glycyrrhetinic acid, which is found in human liver and may play a role in cancer development. ML334 also inhibits the protein–protein interaction between two proteins, one of which is a target gene for cancer cells. This inhibition leads to reduced expression of pro-inflammatory cytokines and improved energy production in hypoxic tumor cells, which are resistant to chemotherapy. ML334 also has detoxification properties due to its ability to inhibit detoxification enzymes such as CYP1A1 and CYP2E1, which may alter the metabolism of various drugs, including insulin.
Formula:C26H26N2O5Purity:Min. 95%Color and Shape:PowderMolecular weight:446.5 g/molRef: 3D-HHC50066
Discontinued product





